Studies on the Toxicity and Binding Kinetics of Abrin in Normal and Epstein Barr Virus-Transformed Lymphocyte Culture-I: Experimental Results – 1

Pathobiology ◽  
1981 ◽  
Vol 49 (6) ◽  
pp. 306-318 ◽  
Author(s):  
Matthew Witten ◽  
Carol E. Bennett ◽  
Armand Glassman
2012 ◽  
Vol 56 (2) ◽  
pp. 93-98 ◽  
Author(s):  
Hidetaka Nakai ◽  
Yoshiki Kawamura ◽  
Ken Sugata ◽  
Hiroko Sugiyama ◽  
Yoshihiko Enomoto ◽  
...  

Blood ◽  
1994 ◽  
Vol 83 (9) ◽  
pp. 2715-2722 ◽  
Author(s):  
A Savoie ◽  
C Perpete ◽  
L Carpentier ◽  
J Joncas ◽  
C Alfieri

Abstract The Epstein-Barr virus (EBV) is known to cause posttransplant lymphoproliferative disease (PTLD) in immunosuppressed transplant patients. The results of this pilot study showed that all EBV- patients pretransplant experienced primary EBV infection within the first 3 months after transplant surgery. Virtually all of these patients had a higher burden of EBV-infected cells in their peripheral blood (PB) after infection by EBV than did the EBV+ pretransplant group when tested at the same intervals posttransplant. Salivary EBV titers also increased in most patients, but the difference between the two groups was statistically significant only at 12 months, whereupon EBV+ patients showed higher titers compared with EBV- (alpha < 0.053). Also, polymerase chain reaction amplification followed by Southern blotting was performed to detect EBV sequences in PB mononuclear cells. This technique allowed confirmation of the blood culture results and constituted a faster alternative compared with the culture assay. The highest increase in the number of EBV-infected lymphocytes at 3 months posttransplant obtained from PB was seen in a patient who developed fatal PTLD and in another with protracted infectious mononucleosis. Thus, the number of EBV-infected cells in PB was found to correlate positively with risk of development of PTLD at 3 months posttransplant in our group of pediatric transplant patients. This study showed that quantitative lymphocyte culture of PB was an accurate index of immunosuppression and a reliable method for assessing the risk of PTLD development.


2010 ◽  
Vol 91 (8) ◽  
pp. 2049-2053 ◽  
Author(s):  
Rain Yamamoto ◽  
Migaku Teramoto ◽  
Ikuo Hayasaka ◽  
Koki Ikeda ◽  
Toshikazu Hasegawa ◽  
...  

Nine male chimpanzees originally reared in solitary cages were set up to form a group. Plasma viral load of the lymphocryptovirus (LCV) of chimpanzee [Epstein–Barr virus chimpanzee (EBVcmp)] was measured by real-time PCR. In the group formation (Form) period, the first-ranking male showed an imminent increase in plasma EBVcmp load compared with 1 week before (pre-Form) and 3 months after (post-Form) group formation. Other upper-ranking males such as the second-, third- and fourth-male also showed the highest level of viral load in the Form period. The kinetics of EBVcmp load in the Form period were statistically different from other periods (against pre-Form, t=−4.878, P<0.001; against post-Form, t=6.434, P<0.001). The effect of the male dominance rank did not differ between the pre-Form and post-Form periods (t=−1.557, P=0.12). Reactivation of LCV (EBV) as an immunological stress marker for humans might also be applied to chimpanzees.


2011 ◽  
Vol 50 (3) ◽  
pp. 244-246 ◽  
Author(s):  
Yo Hoshino ◽  
Kazuo Nishikawa ◽  
Yoshinori Ito ◽  
Kiyotaka Kuzushima ◽  
Hiroshi Kimura

Sign in / Sign up

Export Citation Format

Share Document